Selected Financial Data
since 2005
Income Statement
Bristol-Myers Squibb Co., selected items from income statement, long-term trends
US$ in millions
| 12 months ended: | Revenues | Net earnings (loss) attributable to BMS |
|---|---|---|
| Dec 31, 2024 | 48,300) | (8,948) |
| Dec 31, 2023 | 45,006) | 8,025) |
| Dec 31, 2022 | 46,159) | 6,327) |
| Dec 31, 2021 | 46,385) | 6,994) |
| Dec 31, 2020 | 42,518) | (9,015) |
| Dec 31, 2019 | 26,145) | 3,439) |
| Dec 31, 2018 | 22,561) | 4,920) |
| Dec 31, 2017 | 20,776) | 1,007) |
| Dec 31, 2016 | 19,427) | 4,457) |
| Dec 31, 2015 | 16,560) | 1,565) |
| Dec 31, 2014 | 15,879) | 2,004) |
| Dec 31, 2013 | 16,385) | 2,563) |
| Dec 31, 2012 | 17,621) | 1,960) |
| Dec 31, 2011 | 21,244) | 3,709) |
| Dec 31, 2010 | 19,484) | 3,102) |
| Dec 31, 2009 | 18,808) | 10,612) |
| Dec 31, 2008 | 20,597) | 5,247) |
| Dec 31, 2007 | 19,348) | 2,165) |
| Dec 31, 2006 | 17,914) | 1,585) |
| Dec 31, 2005 | 19,207) | 3,000) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Bristol-Myers Squibb Co., selected items from assets, long-term trends
US$ in millions
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2024 | 29,780) | 92,603) |
| Dec 31, 2023 | 31,770) | 95,159) |
| Dec 31, 2022 | 27,273) | 96,820) |
| Dec 31, 2021 | 33,262) | 109,314) |
| Dec 31, 2020 | 30,192) | 118,481) |
| Dec 31, 2019 | 29,354) | 129,944) |
| Dec 31, 2018 | 17,160) | 34,986) |
| Dec 31, 2017 | 14,854) | 33,551) |
| Dec 31, 2016 | 13,704) | 33,707) |
| Dec 31, 2015 | 10,415) | 31,748) |
| Dec 31, 2014 | 14,608) | 33,749) |
| Dec 31, 2013 | 18,916) | 38,592) |
| Dec 31, 2012 | 9,521) | 35,897) |
| Dec 31, 2011 | 15,318) | 32,970) |
| Dec 31, 2010 | 13,273) | 31,076) |
| Dec 31, 2009 | 13,958) | 31,008) |
| Dec 31, 2008 | 14,763) | 29,552) |
| Dec 31, 2007 | 10,348) | 26,172) |
| Dec 31, 2006 | 10,302) | 25,575) |
| Dec 31, 2005 | 12,283) | 28,138) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Bristol-Myers Squibb Co., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
| Current liabilities | Total liabilities | Total debt | Total BMS shareholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2024 | 23,774) | 76,215) | 49,649) | 16,335) |
| Dec 31, 2023 | 22,262) | 65,674) | 39,772) | 29,430) |
| Dec 31, 2022 | 21,890) | 65,702) | 39,320) | 31,061) |
| Dec 31, 2021 | 21,868) | 73,308) | 44,553) | 35,946) |
| Dec 31, 2020 | 19,080) | 80,599) | 50,676) | 37,822) |
| Dec 31, 2019 | 18,304) | 78,246) | 46,733) | 51,598) |
| Dec 31, 2018 | 10,654) | 20,859) | 7,349) | 14,031) |
| Dec 31, 2017 | 9,563) | 21,704) | 7,962) | 11,741) |
| Dec 31, 2016 | 8,841) | 17,360) | 6,708) | 16,177) |
| Dec 31, 2015 | 8,017) | 17,324) | 6,689) | 14,266) |
| Dec 31, 2014 | 8,461) | 18,766) | 7,832) | 14,852) |
| Dec 31, 2013 | 12,440) | 23,356) | 8,340) | 15,154) |
| Dec 31, 2012 | 8,279) | 22,259) | 7,394) | 13,623) |
| Dec 31, 2011 | 7,780) | 17,103) | 5,491) | 15,956) |
| Dec 31, 2010 | 6,739) | 15,438) | 5,445) | 15,713) |
| Dec 31, 2009 | 6,313) | 16,223) | 6,361) | 14,843) |
| Dec 31, 2008 | 6,710) | 17,311) | 6,739) | 12,241) |
| Dec 31, 2007 | 8,644) | 15,610) | 6,272) | 10,562) |
| Dec 31, 2006 | 6,496) | 15,584) | 7,435) | 9,991) |
| Dec 31, 2005 | 6,890) | 16,930) | 8,595) | 11,208) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
Bristol-Myers Squibb Co., selected items from cash flow statement, long-term trends
US$ in millions
| 12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2024 | 15,190) | (21,352) | 5,127) |
| Dec 31, 2023 | 13,860) | (2,295) | (9,416) |
| Dec 31, 2022 | 13,066) | (1,062) | (16,962) |
| Dec 31, 2021 | 16,207) | (538) | (16,224) |
| Dec 31, 2020 | 14,052) | (10,859) | (1,151) |
| Dec 31, 2019 | 8,067) | (9,770) | 7,621) |
| Dec 31, 2018 | 5,940) | (874) | (3,535) |
| Dec 31, 2017 | 5,275) | (66) | (4,077) |
| Dec 31, 2016 | 2,850) | 1,480) | (2,445) |
| Dec 31, 2015 | 1,832) | (1,572) | (3,351) |
| Dec 31, 2014 | 3,148) | 1,216) | (2,437) |
| Dec 31, 2013 | 3,545) | (572) | (1,068) |
| Dec 31, 2012 | 6,941) | (6,727) | (4,333) |
| Dec 31, 2011 | 4,840) | (1,437) | (2,657) |
| Dec 31, 2010 | 4,491) | (3,812) | (3,343) |
| Dec 31, 2009 | 4,065) | (4,380) | (17) |
| Dec 31, 2008 | 3,707) | 5,079) | (2,582) |
| Dec 31, 2007 | 3,153) | (202) | (3,213) |
| Dec 31, 2006 | 2,083) | 206) | (3,351) |
| Dec 31, 2005 | 1,836) | 1,191) | (3,637) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
Bristol-Myers Squibb Co., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2024 | -4.41 | -4.41 | 2.42 |
| Dec 31, 2023 | 3.88 | 3.86 | 2.31 |
| Dec 31, 2022 | 2.97 | 2.95 | 2.19 |
| Dec 31, 2021 | 3.15 | 3.12 | 2.01 |
| Dec 31, 2020 | -3.99 | -3.99 | 1.84 |
| Dec 31, 2019 | 2.02 | 2.01 | 1.68 |
| Dec 31, 2018 | 3.01 | 3.01 | 1.61 |
| Dec 31, 2017 | 0.61 | 0.61 | 1.57 |
| Dec 31, 2016 | 2.67 | 2.65 | 1.53 |
| Dec 31, 2015 | 0.94 | 0.93 | 1.49 |
| Dec 31, 2014 | 1.21 | 1.20 | 1.45 |
| Dec 31, 2013 | 1.56 | 1.54 | 1.41 |
| Dec 31, 2012 | 1.17 | 1.16 | 1.37 |
| Dec 31, 2011 | 2.18 | 2.16 | 1.33 |
| Dec 31, 2010 | 1.80 | 1.79 | 1.29 |
| Dec 31, 2009 | 5.35 | 5.34 | 1.25 |
| Dec 31, 2008 | 2.65 | 2.63 | 1.24 |
| Dec 31, 2007 | 1.10 | 1.09 | 1.15 |
| Dec 31, 2006 | 0.81 | 0.81 | 1.12 |
| Dec 31, 2005 | 1.53 | 1.52 | 1.12 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.